Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × NSCLC × icotinib × Clear all

Phase

Phase 4 2 Phase 2 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 NSCLC 2 Neoplasms, Second Primary 1 Lung Neoplasms 1 Adenocarcinoma 1

Interventions

icotinib 2 anlotinib 2 Thalidomide 1 Drug Therapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02404675 2017-07-28

INCREASE

Betta Pharmaceuticals Co., Ltd.

Phase 4 Unknown

NSCLC

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Henan Provincial People's Hospital

Phase 4 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡